Treatment options are expanding, and experts are turning their attention to prevention ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

Along with knowing more about Alzheimer’s disease, public education needs to openly address the option of not having to live ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Neuropacs™ Corp. today announced that its Co-Founder & Chief Scientific Officer, Dr. David Vaillancourt, will serve as a key scientific leader in a $22 million National Institutes of Health grant ...

SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.

People came out Saturday in Williamstown to join the fight to end Alzheimer’s during the Alzheimer’s Association Walk to End ...

Social media posts about blood tests meant to aid in the diagnosis of Alzheimer’s disease often leave out critical ...

Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) tracks blood metabolite changes after repetitive transcranial magnetic stimulation (rTMS)-cognitive training therapy.